Like p53, the Proliferation-Associated Protein p120 Accumulates in Human Cancer Cells Following Exposure to Anticancer Drugs
- 17 March 1998
- journal article
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 244 (2) , 368-373
- https://doi.org/10.1006/bbrc.1998.8278
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- Loss of function and p53 protein stabilizationOncogene, 1997
- Paclitaxel-resistant Human Ovarian Cancer Cells Have Mutant β-Tubulins That Exhibit Impaired Paclitaxel-driven PolymerizationJournal of Biological Chemistry, 1997
- p53, the Cellular Gatekeeper for Growth and DivisionCell, 1997
- In vitro evaluation of ap53-expressing adenovirus as an anti-cancer drugInternational Journal of Cancer, 1996
- Nucleolar p120 is expressed as a delayed early response gene and is inducible by DNA‐damaging agentsJournal of Cellular Physiology, 1995
- Cell cycle regulated expression of nucleolar antigen P120 in normal and transformed human fibroblastsJournal of Cellular Physiology, 1993
- UV irradiation stimulates levels of p53 cellular tumor antigen in nontransformed mouse cells.Molecular and Cellular Biology, 1984
- Growth regulation of a cellular tumour antigen, p53, in nontransformed cellsNature, 1984
- Two distinct mechanisms regulate the levels of a cellular tumor antigen, p53.Molecular and Cellular Biology, 1983
- Microinjection of monoclonal antibody to protein p53 inhibits serum-induced DNA synthesis in 3T3 cells.Proceedings of the National Academy of Sciences, 1982